http://purl.org/np/RAVCqO13TX... RAVCqO13TX

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#type type

http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement Statement

0000-0002-7641-6446

2021-05-25T12:35:02.341Z

http://purl.org/np/RAVCqO13TX... RAVCqO13TX

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/2000/01/rdf-schema#label label

However, other atypical antipsychotics, such as lurasidone, are often considered for off-label use in the treatment of irritability, whether because of tolerability issues with risperidone and aripiprazole or because of the drug-refractory nature of this symptom cluster.

0000-0002-7641-6446

2021-05-25T12:35:02.341Z

http://purl.org/np/RAVCqO13TX... RAVCqO13TX

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#object object

http://purl.obolibrary.org/obo/HP_0000737 HP_0000737

0000-0002-7641-6446

2021-05-25T12:35:02.341Z

http://purl.org/np/RAVCqO13TX... RAVCqO13TX

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate predicate

https://w3id.org/biolink/vocab/treats treats

0000-0002-7641-6446

2021-05-25T12:35:02.341Z

http://purl.org/np/RAVCqO13TX... RAVCqO13TX

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#subject subject

https://go.drugbank.com/drugs/DB08815 DB08815

0000-0002-7641-6446

2021-05-25T12:35:02.341Z

http://purl.org/np/RAVCqO13TX... RAVCqO13TX

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/has_population_context has_population_context

http://purl.org/np/RAVCqO13TX...#cohort cohort

0000-0002-7641-6446

2021-05-25T12:35:02.341Z

http://purl.org/np/RAVCqO13TX... RAVCqO13TX

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/publications publications

https://pubmed.ncbi.nlm.nih.gov/28685626/ pubmed.ncbi.nlm.nih.gov/28685626

0000-0002-7641-6446

2021-05-25T12:35:02.341Z

http://purl.org/np/RAVCqO13TX... RAVCqO13TX

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/association_type association_type

https://w3id.org/biolink/vocab...OrPhenotypicFeatureAssociation ChemicalToDiseaseOrPhenotypicFeatureAssociation

0000-0002-7641-6446

2021-05-25T12:35:02.341Z

http://purl.org/np/RAVCqO13TX... RAVCqO13TX

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/provided_by provided_by

https://w3id.org/um/NeuroDKG NeuroDKG

0000-0002-7641-6446

2021-05-25T12:35:02.341Z

http://purl.org/np/RAVCqO13TX... RAVCqO13TX

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/relation relation

https://w3id.org/um/neurodkg/OffLabelIndication OffLabelIndication

0000-0002-7641-6446

2021-05-25T12:35:02.341Z